SFX by Ex Libris Inc.

Title:	Omomyc expression in skin prevents Myc-induced papillomatosis
Source:	Cell death and Differentiation [1350-9047] Soucek, L yr:2004

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Arvanitis, C. "Conditional transgenic models define how MYC initiates and maintains tumorigenesis." Seminars in cancer biology 16.4 (2006): 313-7.
description	2.	Nasi, S. "Molecular recognition in helix-loop-helix and helix-loop-helix leucine zipper domains - Design of repertoires and selection of high affinity ligands for natural proteins." The Journal of biological chemistry 278.14 (2003): 12182-12190.
description	3.	Zheng, H. "Pten and p53 Converge on c-Myc to Control Differentiation, Self-renewal, and Transformation of Normal and Neoplastic Stem Cells in Glioblastoma." Cold Spring Harbor symposia on quantitative biology 73.Control (2009): 427-437.
description	4.	de, A. "Analysis of C-MYC function in normal cells via conditional gene-targeted mutation." Immunity 14.1 (2001): 45-55.
description	5.	Gagandeep, S. "Overexpression of Mad transcription factor inhibits proliferation of cultured human hepatocellular carcinoma cells along with tumor formation in immunodeficient animals." The journal of gene medicine 2.2 (2000): 117-27.
description	6.	Kawamura, T. "Linking the p53 tumour suppressor pathway to somatic cell reprogramming." Nature 460.7259 (2009): 1140-4.
description	7.	L, X u. "Complex transcriptional regulation of myc family gene expression in the developing mouse brain and liver." Molecular and cellular biology 11.12 (1991): 6007-.
description	8.	Turner, R. "Taking myc to the max." Nature structural biology 10.3 (2003): 157-157.
description	9.	Murphy, Anthony J. "Distinct Thresholds Govern Myc's Biological Output In Vivo." Cancer cell 14.6 (2008): 447-457.
description	10.	DePinho, N A. "Repression by the Mad(Mxi1)-Sin3 complex." BioEssays 20.10 (1998): 808-18.
description	11.	Greenwald, R. "CTLA-4 regulates induction of anergy in vivo." Immunity 14.2 (2001): 145-155.
description	12.	Ying, H. "p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation." Nature 455.7216 (2008): 1129-33.
description	13.	Kawakami, T., Chano, T., Minami, K., Okabe, H., Ok, T. "Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma." Human molecular genetics 15.6: 821-30.
description	14.	Luo, H. "c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations." Blood 106.7 (2005): 2452-61.
description	15.	Van Dyke, T. "Cancer modeling in the modern era: progress and challenges." Cell 108.2 (2001): 135-44.
description	16.	Orsulic, S. "Induction of ovarian cancer by defined multiple genetic changes in a mouse model system." Cancer cell 1.1 (2002): 53-62.
description	17.	Knudson, C. "Bax-deficient mice with lymphoid hyperplasia and male germ cell death." Science 270.5233: 96-9.
description	18.	Polo, J. "Immortalization eliminates a roadblock during cellular reprogramming into iPS cells." Nature 460.7259 (2009): 1145-1148.
description	19.	Banito, A. "Senescence impairs successful reprogramming to pluripotent stem cells." Genes & development 23.18 (2009): 2134-2139.
description	20.	Thompson, C B M. "The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues." Molecular cell 6.6 (2001): 1389-99.